Newsfeeds - Spark Newswire

1 minute read

Gossamer Bio Q2 EPS $(0.80) Misses $(0.76) Estimate

Today, 1:48 PM

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.76) by 5.26 percent. This is a 20 percent increase over losses of $(1.00) per share from the

GOSS

14 minute read

Earnings Scheduled For August 9, 2021

By Benzinga Insights

Today, 1:48 PM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.

ACM

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 1:48 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

7 minute read

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street

By Shanthi Rexaline

Today, 1:48 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19)

ABIO

5 minute read

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study

By Shanthi Rexaline

Today, 1:48 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15)

ABCL

11 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 1:48 PM

During the morning session on Thursday, 152 stocks hit new 52-week lows.

ABCL

6 minute read

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs

By Shanthi Rexaline

Today, 1:48 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)

ABCL

1 minute read

Gossamer Bio Announces GB004 Clinical Trial Data Presentations At 2021 Virtual Congress Of The European Crohn’s And Colitis Organisation Jul. 8

By Bill Haddad

Today, 1:48 PM

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and

GOSS

5 minute read

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy’s Launches Generic Vascepa, Halozyme Strikes Licensing Deal

By Shanthi Rexaline

Today, 1:48 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21)

ABCL

2 minute read

Gossamer Bio Names Richard Aranda As Chief Medical Officer

By Benzinga Newsdesk

Today, 1:48 PM

Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing

GOSS